A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL

AL PeaceBrewer, LG Tussey, M Matsui, GX Li, Daniel Quinn, JA Frelinger

    Research output: Contribution to journalArticle

    118 Citations (Scopus)

    Abstract

    Mutating the HLA-A*0201 heavy chain from threonine to lysine at position 134 (T134K) results in a molecule that presents exogenous peptide, but cannot present endogenously derived antigen. This is reflected in diminished cell surface expression and altered intracellular trafficking of T134K. The failure of T134K to present endogenous antigen can be overcome by using an ER targeting sequence, suggesting that the antigen presentation defect is restricted to TAP-dependent peptide loading. The ability of T134K to load peptide in a TAP-dependent manner is dramatically reduced compared with HLA-A*0201. By coimmunoprecipitation there is no detectable association of the T134K molecule with the TAP complex. Thus, T134K selectively affects TAP association and peptide loading, suggesting a requirement for the direct interaction of MHC class I heavy chain and the TAP complex for efficient presentation of endogenous antigen.
    LanguageEnglish
    Pages505-514
    JournalImmunity
    Volume4
    Issue number5
    DOIs
    Publication statusPublished - May 1996

    Fingerprint

    trypsinogen activation peptide
    Antigen Presentation
    Point Mutation
    Viruses
    Antigens
    Peptides
    Threonine
    Lysine
    HLA-A*02:01 antigen

    Cite this

    PeaceBrewer, AL ; Tussey, LG ; Matsui, M ; Li, GX ; Quinn, Daniel ; Frelinger, JA. / A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. In: Immunity. 1996 ; Vol. 4, No. 5. pp. 505-514.
    @article{7cc6275b6c594bd58a869da26b0b0712,
    title = "A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL",
    abstract = "Mutating the HLA-A*0201 heavy chain from threonine to lysine at position 134 (T134K) results in a molecule that presents exogenous peptide, but cannot present endogenously derived antigen. This is reflected in diminished cell surface expression and altered intracellular trafficking of T134K. The failure of T134K to present endogenous antigen can be overcome by using an ER targeting sequence, suggesting that the antigen presentation defect is restricted to TAP-dependent peptide loading. The ability of T134K to load peptide in a TAP-dependent manner is dramatically reduced compared with HLA-A*0201. By coimmunoprecipitation there is no detectable association of the T134K molecule with the TAP complex. Thus, T134K selectively affects TAP association and peptide loading, suggesting a requirement for the direct interaction of MHC class I heavy chain and the TAP complex for efficient presentation of endogenous antigen.",
    author = "AL PeaceBrewer and LG Tussey and M Matsui and GX Li and Daniel Quinn and JA Frelinger",
    year = "1996",
    month = "5",
    doi = "10.1016/S1074-7613(00)80416-1",
    language = "English",
    volume = "4",
    pages = "505--514",
    journal = "Immunity",
    issn = "1074-7613",
    publisher = "Elsevier",
    number = "5",

    }

    A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. / PeaceBrewer, AL; Tussey, LG; Matsui, M; Li, GX; Quinn, Daniel; Frelinger, JA.

    In: Immunity, Vol. 4, No. 5, 05.1996, p. 505-514.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL

    AU - PeaceBrewer, AL

    AU - Tussey, LG

    AU - Matsui, M

    AU - Li, GX

    AU - Quinn, Daniel

    AU - Frelinger, JA

    PY - 1996/5

    Y1 - 1996/5

    N2 - Mutating the HLA-A*0201 heavy chain from threonine to lysine at position 134 (T134K) results in a molecule that presents exogenous peptide, but cannot present endogenously derived antigen. This is reflected in diminished cell surface expression and altered intracellular trafficking of T134K. The failure of T134K to present endogenous antigen can be overcome by using an ER targeting sequence, suggesting that the antigen presentation defect is restricted to TAP-dependent peptide loading. The ability of T134K to load peptide in a TAP-dependent manner is dramatically reduced compared with HLA-A*0201. By coimmunoprecipitation there is no detectable association of the T134K molecule with the TAP complex. Thus, T134K selectively affects TAP association and peptide loading, suggesting a requirement for the direct interaction of MHC class I heavy chain and the TAP complex for efficient presentation of endogenous antigen.

    AB - Mutating the HLA-A*0201 heavy chain from threonine to lysine at position 134 (T134K) results in a molecule that presents exogenous peptide, but cannot present endogenously derived antigen. This is reflected in diminished cell surface expression and altered intracellular trafficking of T134K. The failure of T134K to present endogenous antigen can be overcome by using an ER targeting sequence, suggesting that the antigen presentation defect is restricted to TAP-dependent peptide loading. The ability of T134K to load peptide in a TAP-dependent manner is dramatically reduced compared with HLA-A*0201. By coimmunoprecipitation there is no detectable association of the T134K molecule with the TAP complex. Thus, T134K selectively affects TAP association and peptide loading, suggesting a requirement for the direct interaction of MHC class I heavy chain and the TAP complex for efficient presentation of endogenous antigen.

    U2 - 10.1016/S1074-7613(00)80416-1

    DO - 10.1016/S1074-7613(00)80416-1

    M3 - Article

    VL - 4

    SP - 505

    EP - 514

    JO - Immunity

    T2 - Immunity

    JF - Immunity

    SN - 1074-7613

    IS - 5

    ER -